Nearly all patients quit weight loss shots within two years, study finds
July 11, 2024 An article by Endpoints.com cited a study that found that only about 15% of people who began taking GLP-1 drugs such as
Employers and Insurers Push Back on GLP-1 Drugs Coverage
June 13, 2024 Just 33% of employers and health plans cover the drugs for obesity, according to a report published Tuesday by consultant firm Pharmaceutical
Kroger’s Little Clinics Adds GLP-1 Drugs To Its Weight Loss Program
June 11, 2024 Kroger Health’s The Little Clinic LLC is announcing a renewed approach to its weight management program, offering a holistic and personalized approach
Most weight loss drug users quit before seeing benefits
May 22, 2024 A majority of patients taking weight loss drugs discontinue use of their medication before reaching a clinically meaningful health benefit, according to new
Medifast To Launch National Marketing Campaign
May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering
Novo Nordisk Working On Even Better Weight Loss Drugs
May 9, 2024 Novo Nordisk is beginning work on a follow-up weight loss medicine that would last longer and could be manufactured more easily. On
How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast
May 9, 2024 John LaRosa, Marketdata’s Research Director and founder, was recently interviewed by Kimberly Adams at Marketplace, a business and economic program, along with
Weight Watchers Reports Q1 Results
May 2, 2024 Management reported that: “We delivered solid performance in the first quarter with end of period subscribers of 4.0 million, improved retention and